The Patent Finder

Anaerobic Blood Storage and Pathogen Inactivation Method

Hemanext Inc.

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. 4 of these applications claim priority to application PCT/US2017/034410, filed May 25, 2017. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
PatentTitleHolderStatusExpiresTime remainingConfidence
US 10,583,192Anaerobic Blood Storage and Pathogen Inactivation Method
In force
 · Low confidence
Hemanext Inc.In force
Low confidence
US 11,147,876Anaerobic Blood Storage and Pathogen Inactivation Method
In force
 · High confidence
Hemanext Inc.In force
High confidence
US 11,911,471Anaerobic Blood Storage and Pathogen Inactivation Method
In force
 · High confidence
Hemanext Inc.In force
High confidence
US 12,364,760Anaerobic Blood Storage and Pathogen Inactivation Method
In force
 · Medium confidence
Hemanext Inc.In force
Medium confidence
Application 19/244,365Anaerobic Blood Storage and Pathogen Inactivation Method
Pending
Not granted
Hemanext Inc.PendingNot granted
5 of 5 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
4 of these are in force and held by Hemanext Inc..
Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited